Filing Flows › Comparisons › ENTA vs TNXP
Enanta Pharmaceuticals vs Tonix Pharmaceuticals Holding: ENTA and TNXP compared
Enanta Pharmaceuticals is the larger company: $14.4M of revenue in its latest quarter (Q3 FY26) against $13.5M for Tonix Pharmaceuticals Holding (Q2 2026). Tonix Pharmaceuticals Holding is growing faster (+578% against -22% a year earlier). Enanta Pharmaceuticals is more profitable, with an operating margin of -120.0% against -314.1%.
Where the money goes: ENTA and TNXP
Enanta Pharmaceuticals (ENTA) · Q3 FY26
Enanta Pharmaceuticals, Q3 FY26: revenue $14.4M (-22% year over year), operating margin -120.0%, net loss $19.5M, operating cash flow −$10.0M. The chart follows the revenue to costs, profit and cash.
Tonix Pharmaceuticals Holding (TNXP) · Q2 2026
Tonix Pharmaceuticals Holding, Q2 2026: revenue $13.5M (+578% year over year), operating margin -314.1%, net loss $40.6M, operating cash flow −$42.2M. The chart follows the revenue to costs, profit and cash.
| Enanta Pharmaceuticals (ENTA) | Tonix Pharmaceuticals Holding (TNXP) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q2 2026 |
| Revenue | $14.4M | $13.5M |
| Revenue growth, Y/Y | -22% | +578% |
| Operating margin | -120.0% | -314.1% |
| Net earnings | −$19.5M | −$40.6M |
| Net margin | -135.8% | -299.4% |
| Operating cash flow | −$10.0M | −$42.2M |
Where the revenue comes from
Tonix Pharmaceuticals Holding
- Tonmya: $11.0M (81%)
- Zembrace Symtouch: $2.0M (15%)
- Tosymra: $594K (4%)
Questions
Which is bigger, Enanta Pharmaceuticals or Tonix Pharmaceuticals Holding?
Enanta Pharmaceuticals is the larger company: $14.4M of revenue in its latest quarter (Q3 FY26) against $13.5M for Tonix Pharmaceuticals Holding (Q2 2026).
Is Enanta Pharmaceuticals or Tonix Pharmaceuticals Holding growing faster?
Tonix Pharmaceuticals Holding is growing faster (+578% against -22% a year earlier).
Which is more profitable, Enanta Pharmaceuticals or Tonix Pharmaceuticals Holding?
Enanta Pharmaceuticals is more profitable, with an operating margin of -120.0% against -314.1%.
More: Enanta Pharmaceuticals earnings · how Enanta Pharmaceuticals makes money · Tonix Pharmaceuticals Holding earnings · how Tonix Pharmaceuticals Holding makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.